Robert A. Stern, PhD

Robert A. Stern, PhD, is a neurologist at Boston Medical Center (BMC) and a professor of neurology at Boston University Chobanian and Avedisian School of Medicine. He is also the co-founder and director of Clinical Research for the Boston University Chronic Traumatic Encephalopathy (CTE) Center. His research focuses on the long-term consequences of repetitive head impacts, including the neuropathological risk factors (e.g., genetic and head impact exposure), neuroimaging, biomarker development, and clinical diagnosis and descriptions of the neurodegenerative disease, CTE. He is currently lead PI of an NINDS-funded, 7-year, multicenter project examining these issues. From 2010-2019, he was the Clinical Core Director of the NIA-funded Boston University Alzheimer’s Disease Center (ADC). He continues to work with the ADC as a Senior Investigator. In these roles, he oversees a multidisciplinary group of scientists and clinicians, directs the center’s longitudinal research registry, and directs several NIH- and industry-funded diagnostic, prevention, and treatment trials. His other areas of research include diagnosis, risk factors, and treatment of cognitive decline and neuropsychiatric dysfunction in aging. He has also published extensively on the psychometric properties of many widely used tests in neuropsychology, as well as the use of various instruments and biomarkers in the differential diagnosis of Alzheimer’s disease (AD) and AD Related Dementias (ADRD). In addition, he has developed several commonly used tests and instruments, including the Neuropsychological Assessment Battery (NAB).